Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro Following Single-Dose Administration in Healthy Subjects

Next Previous
X
Search
Trial Profile

Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro Following Single-Dose Administration in Healthy Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 07 Jun 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin lispro (Primary)
  • Indications Diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Eli Lilly and Company

    • Most Recent Events

    • 27 May 2021 Results of pooled analysis of 4 studies (NCT02942654, NCT03286751, NCT03166124, and NCT03305822) comparing and assessing the consistency of pharmacokinetics and glucodynamics between URLi and Humalog in healthy subjects and patients with T1D or T2D, published in the Clinical Pharmacokinetics.
    • 25 Sep 2020 Results of a pooled analysis of data pooled from 4 randomized trials (NCT02942654, NCT03305822, NCT03166124, NCT03286751) assessing the consistency of the pharmacokinetics and glucodynamics between URLi and Lispro in healthy subjects and patients with type 1 diabetes or type 2 diabetes, presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
    • 06 Jan 2017 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top